Yahoo Finance Top Research Reports for NVIDIA, Amazon.com & UnitedHealth
Thursday, June 27, 2024
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corporation (NVDA), Amazon.com, Inc. (AMZN) and UnitedHealth Group Incorporated (UNH). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
NVIDIA shares have truly emerged as the poster child to for the market's AI enthusiasm. It is the chipmaker's AI leverage that has made the stock of of the most valuable publicly-traded company in the world in recently. The stock has lost some altitude lately, on creeping worries about the sustainability of the AI momentum and broader Tech spending trends.
The data center end-market business is benefiting from the growing demand for generative AI and large language models using graphic processing units (GPUs) based on NVIDIA Hopper and Ampere architectures. A surge in hyperscale demand and higher sell-ins to partners across the Gaming and ProViz end markets following the normalization of channel inventory are acting as tailwinds.
Collaborations with Mercedes-Benz and Audi are likely to advance its presence in the autonomous vehicles and other automotive electronics space. However, its near-term prospects are likely to be hurt by softening IT spending amid macroeconomic headwinds.
(You can read the full research report on NVIDIA here >>>)
Shares of Amazon.com have outperformed the Zacks Internet - Commerce industry over the year-to-date period (+28.7% vs. +19.8%). The company is gaining on solid Prime momentum owing to ultrafast delivery services and strong content portfolio. Strengthening relationship with third-party sellers is a positive.
Strong adoption rate of AWS is aiding the company’s cloud dominance. Improving Alexa skills along with robust smart home products offerings are tailwinds. Robust advertising business is also contributing well. The company’s strong global presence and solid momentum among the small and medium businesses remain a plus.
Growing capabilities in grocery, pharmacy, healthcare and autonomous driving are other positives. Deepening focus on generative AI is a major plus. However, macroeconomic challenges remain headwinds. Rising transportation and fulfillment center costs are concerns.
(You can read the full research report on Amazon.com here >>>)
UnitedHealth shares have gained +2.1% over the past year against the Zacks Medical - HMOs industry’s gain of +3.2%. The company’s top line remains poised for growth on the back of a strong market position, new deals, renewed agreements and expansion of service offerings.
UnitedHealth’s solid health services segment provides diversification benefits. The Government business remains well-poised for growth in the future. Adjusted net earnings per share are anticipated to be in the $27.5-$28.00 band in 2024, higher than the 2023 reported figure of $25.12. A sturdy balance sheet enables business investments and prudent deployment of capital via share repurchases and dividend payments.
In June 2024, management approved a 11.7% hike in the quarterly dividend. However, membership in its global business continues to be a concern. High operating costs due to rising medical expenses are hurting margins. As such, the stock warrants a cautious stance.
(You can read the full research report on UnitedHealth here >>>)
Other noteworthy reports we are featuring today include FedEx Corporation (FDX), DuPont de Nemours, Inc. (DD) and ResMed Inc. (RMD).
Director of Research
Sheraz Mian
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
NVIDIA (NVDA) Rides on Strong Adoption of GPUs, Partnerships
Amazon (AMZN) Banks on Prime Momentum & Growing AWS Adoption
Solid Top Line & Strong Cash Flows Drive UnitedHealth (UNH)
Featured Reports
FedEx's (FDX) Dividend Payouts Aid Amid Shipping Volume Woes
The Zacks analyst is impressed with the company's efforts to reward its shareholders. FDX's cost-cut initiatives support the bottom line. However, shipping volume-related weakness is a major concern.
Productivity Actions, New Products Aid DuPont (DD)
Per the Zacks analyst, DuPont's cost and productivity improvement actions will support its margins. It should also gain from new product launches in high-growth markets.
Robust 5G Coverage to Aid Telefonica (TEF) Amid Stiff Rivalry
Per the Zacks analyst, Telefonica's extensive 5G footprint across Spain, Germany and Brazil is solidifying its position. However, fierce competition in the telecommunication space is a major concern.
Carlyle's (CG) Solid AUM Aids Organic Growth Amid High Costs
Per the Zacks analyst, a rise in AUM balance along with efforts to expand its investment platforms will drive Carlyle's top-line growth. However, high costs and lower liquidity level are concerns.
Focus on Clean Assets & Investments Aid Alliant Energy (LNT)
Per the Zacks analyst, Alliant Energy's investment of around $9.1 billion through 2027, will strengthen its operations. Adding more clean assets in generation portfolio will drive its performance.
SM Energy (SM) Banks On High-Grade Austin Chalk Inventory
The Zacks analyst is impressed by SM Energy's high-quality inventory of the Austin Chalk play, leading to encouraging results due to additional wells drilled in the region.
Helmerich & Payne (HP) to Gain from Proprietary FlexRigs
The Zacks analyst believes that Helmerich & Payne's technologically advanced FlexRigs help it to maintain strong margins but is worried over the substantial upfront investments in Saudi Arabia.
New Upgrades
ResMed (RMD) Gains from the AirSense Platforms,Masks Sales
Per the Zacks analyst, the steady availability of AirSense 10 and AirSense 11 cloud-connected sleep devices drive ResMed's sales. The Masks and Accessories business thrives amid fierce competition.
Hinowa Buyout and Strong Balance Sheet Aid Oshkosh (OSK)
Per the Zacks analyst, the acquisition of Hinowa opens up growth avenues for Oshkosh in core and adjacent markets. Low leverage also gives it enough flexibility to tap into growth opportunities.
Ryder (R) Banks on Dividends, Buybacks & Used Vehicle Market
The Zacks analyst likes the company's efforts to reward its shareholders through dividends and buybacks. The improving used vehicle market is another tailwind.
New Downgrades
B&G Foods' (BGS) Sales Hurt by Soft Foodservice Business
Per the Zacks analyst, B&G Foods is battling challenges in its foodservice business due to soft out-of-home traffic. Additionally, slow recovery of sales to retail customers led to lowered sales view.
QuidelOrtho (QDEL) Plagued by Dependence on Diagnostic Tests
Per the Zacks analyst, stiff competition and over dependence on diagnostic tests will likely hinder QuidelOrtho's top-line growth. However, strong product portfolio raises optimism
Softer Comps Growth Hurt Cracker Barrel's (CBRL) Prospects
Per the Zacks analyst, Cracker Barrel's prospects are hurt due to a decline in guest traffic, on the back of ongoing inflationary pressures and macroeconomic risks, thus resulting in softer comps.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Amazon.com, Inc. (AMZN) : Free Stock Analysis Report
UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
DuPont de Nemours, Inc. (DD) : Free Stock Analysis Report
ResMed Inc. (RMD) : Free Stock Analysis Report
FedEx Corporation (FDX) : Free Stock Analysis Report
